AI Article Synopsis

  • Prolactin (PRL) is crucial for mammary development and lactation, but its roles in female reproduction and pregnancy are still being explored.
  • Research shows that PRL enhances the ability of monocytes to express the enzyme indoleamine 2,3-dioxygenase (IDO) when exposed to lower levels of interferon-gamma (IFN-gamma), albeit without disrupting standard IFN-gamma signaling pathways.
  • This priming effect of PRL on monocytes suggests it plays an important role in enabling IDO expression during pregnancy, thus contributing to maternal-fetal tolerance and successful pregnancies.

Article Abstract

Prolactin (PRL) was originally identified by its ability to stimulate mammary development and lactation, and its essential roles other than lactation have recently been implicated in female reproduction. However, little is known about PRL-mediated events in pregnancy. The tryptophan catabolism enzyme indoleamine 2,3-dioxygenase (IDO) is interferon-gamma (IFN-gamma)-inducible and has recently become a focus for maternal-fetal tolerance for successful pregnancy. Based on recognition that PRL is one of the up-regulated hormones in pregnancy, in a previous study we have shown that PRL induces IDO expression in monocytes in cooperation with a suboptimal concentration of IFN-gamma. Here, we demonstrate that PRL sensitizes monocytes to induce IDO expression in response to low doses of IFN-gamma without affecting the typical IFN-gamma signaling events, such as STAT1 phosphorylation and IRF-1 induction. In addition, IDO induction in these cell cultures was observed only after 24 h pre-exposure to PRL. These results indicate a priming effect of PRL on monocytes that occurs before IFN-gamma signaling and increases their sensitivity to IFN-gamma for IDO induction, rather than a synergistic effect of PRL and IFN-gamma on IDO induction. These results offer new insights into the roles of PRL in female reproduction, as well as provide a better understanding as to how IDO expression is regulated and achieved in pregnancy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jri.2007.08.003DOI Listing

Publication Analysis

Top Keywords

ido expression
16
ifn-gamma signaling
12
ido induction
12
prl
9
prolactin prl
8
prl sensitizes
8
indoleamine 23-dioxygenase
8
ido
8
23-dioxygenase ido
8
female reproduction
8

Similar Publications

Bacillus subtilis-derived-exopolysaccharide halts depigmentation and autoimmunity in vitiligo.

J Invest Dermatol

December 2024

Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago (IL), USA; Department of Pulmonary and Critical Care Medicine, University of Virginia, Charlottesville, VA, USA. Electronic address:

Vitiligo has a complex multifactorial etiology involving a T-cell mediated autoimmune response to cutaneous melanocytes. Microbial dysbiosis has been assigned a contributing role in vitiligo etiology. Treating vitiligo can be a challenging task and finding novel treatment approaches is crucial.

View Article and Find Full Text PDF

Background: Although MDSCs are widely recognized for their immunoinhibitory effects in pathological conditions, their function during HIV infection particularly within the mechanisms underlying incomplete immune recovery remains elusive.

Methods: We conducted a cross-sectional study in which 30 healthy controls and 62 HIV-1-infected subjects [31 immunological non-responders (INRs) and 31 immunological responders (IRs)] were selected. The proportion of MDSCs was determined in each category of participants.

View Article and Find Full Text PDF

Dendritic cells (DCs) are essential for promoting T lymphocyte responses since they are specialist antigen-presenting cells. In order to maintain tolerance or initiate immune responses, DCs must be activated in a balanced and regulated manner via diverse signaling pathways. By using a variety of pharmacological components, we can interfere with their different signaling pathways such as the mammalian target of rapamycin (mTOR) to appropriately modulate DC activity.

View Article and Find Full Text PDF

To investigate the regulatory mechanism of indoleamine 2, 3-dioxygenase (IDO) in T lymphocyte differentiation and its role in promoting the growth of gastric cancer (GC) cells through the PI3K/Akt/mTOR pathway. GC cell lines (MFC and NCI-N87) and PBMC cells were co-cultured and IDO inhibitor 1-methyl-tryptophan (1-MT) was added. The proliferation was detected by CCK-8, the apoptosis was detected by flow cytometry, and the contents of TNF-α, IL-1β, IL-6, IL-8, and INF-γ were detected by ELISA.

View Article and Find Full Text PDF

Increased IDO expression and regulatory T cells in acute myeloid leukemia: implications for immune escape and therapeutic targeting.

Blood Res

December 2024

Department of Cellular and Molecular Biology, Faculty of Biological Sciences, North Tehran Branch, Azad University, Tehran, Iran.

Purpose: This study aimed to determine the frequency of regulatory T cells (Tregs) (CD4/FOXP3) and indoleamine 2,3-dioxygenase (IDO) expression in patients with acute myeloid leukemia (AML).

Methods: This cross-sectional case-control study was conducted between Jan 2022 and Dec 2023. Bone marrow samples were collected from 20 healthy individuals and 15 patients with AML.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!